1 |
Ministry of Health and Welfare, Ministry of Food and Drug Safety, and Korea Health Industry Development Institute. Report on "Plans on "Columbus Project" - National Strategies for Great Health Technology and Globalization by 2020". January 26, 2011.
|
2 |
Workshop "Strategies to launch in global pharmaceutical market".Yonsei University, Seoul. (2011).
|
3 |
Korea Health Industry Development Institute. The environmental change of global pharmaceutical industry. Report of Korea Health Industry Statistics System.Vol.04, 5 (2010).
|
4 |
IMS Institute for Healthcare Informatics: The global use of medicines: Outlook trough 2015. IMS Health. 2011. Available at: http://www.imshealth.com/deployedfiles/ims/Global/ Content/Insights/IMS%20Institute%20for%20Healthcare %20Informatics/Global_Use_of_Medicines_Report.pdf Accessed at 20th June 2011.
|
5 |
Smith B D. The future of pharma : Evolutionary threats and opportunities. 1st ed., Ashgate Pub Co, USA, p. 194 (2011).
|
6 |
Docteur E: Pharmaceutical pricing policies in a global market. OECD Health Policy Studies, Paris. 2012, 22 (2007).
|
7 |
Leopold C, Vogler S, Mantel-Teeuwisse AK, et al., Differneces in external price referencing in europe: A descriptive overview. Health Policy 2012; 104: 50.
DOI
|
8 |
Scherer F. The pharmaceutical industry-prices and progress. NEJM 2004; 927: 351
|
9 |
IMS Health Data: Global pharma forecast pack. (2010).
|
10 |
Anonymous: FDA seeks stricter guidelines for advisory approval panels. Quality Progress. 40, 12 (2007).
|
11 |
Carpenter D, Chernew M, Smith DG, et al. Approval times for new drugs: Does the source of funding for FDA staff matter? Health Aff (Millwood). Suppl Web Exclusives, W3 (2003).
|
12 |
New drug development and review process. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/ SmallBusinessAssistnace/ucm053131.htm (Accessed at 25th July 2012)
|
13 |
DIK plus homeplage. Available at: http://www. dikplus.co.kr (Accessed at 13th July 2012)
|
14 |
Korea National Enterprise for Clinical Trials. http://www. konect.or.kr (Accessed at 25th July 2012)
|
15 |
Trius Therapeutics : 2011 annual report. Available at: http:/ /investor.triusrx.com/common/download/download.cfm ?companyid=ABEA-43S70D&fileid=559924&filekey= dcb7b043-b25c-40a6-a41b-086b647f41bc&filename= TRIUS_THERAPEUTICS_INC_2011_ANNUAL_REPOR T_Final_As_Printed.pdf ( Accessed at 20th June 2012)
|